- NPMI

Muscat Securities Market (Sultanat of Oman)
0.12 Last Update 27/05/2018 14:05 KSA
× lblWarning! {{companyMessage}}
  • :0.12
  • :0.12
  • ('000):50,000
  • (OMR '000):5,800
  • :-0.03


  • 0
  • :102
  • :0
  • 52-W L52-W H
    0.12
    0.00000.12
  • -
  • -


  • 0

  • (OMR):

    0
  • (OMR):12
  • :0
  • Performance Comparison

Activities

National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.

  • Chairman:
    Ghazi O. Al Zubeidi
  • Vice-chairman:
    Abdullah M. B. Al Qenaei
  • CEO:
    G . Sridhar
  • Board Members:

    Amal S. Bahwan

    Khalifa S. Al Mohannadi

    Mahmoud A. Zubaid

    Omar S. Bahwan

  • Auditors:

    Moore Stephens

CMA clears OMR5m rights issue of National Pharmaceuticals (Times of Oman - 24/12/2017)

National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
12/04/2018 3-Month 31/03/2018 00 16.39
14/01/2018 12-Month 31/12/2017 02 21.33
12/10/2017 9-Month 30/09/2017 01 7.05
12/07/2017 6-Month 30/06/2017 01 -9.96
12/04/2017 3-Month 31/03/2017 00 5.06
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
MOUASAT 2,438.48 180 -2.67 29.31 25.59 6.58 1.64 0.72 13.85 22.49
DALLAHHEALTH 1,525.18 94.9 -2.54 -1.97 21.35 3.52 2.58 0.9 12.1 17.53
MEAHCO 1,398.13 56.6 -0.81 -26.14 18.92 3.21 3.51 0.78 11.92 18.76
SPIMACO 976.99 30.55 -0.27 -12.46 24.22 1.39 3.27 0.85 8.47 15.11
CARE 671.73 55.6 -1.25 22.02 26.43 2.61 1.78 0.92 -0.59 -0.89
JULPHAR 642.96 2.1 0 -4.11 33.87 1.02 5.27 0.26 4.09 0
ATC.KSE 547.65 1,100 0 0 18.48 3.34 1.82 -0.01 2.93 12.88
MCGS 437.27 57.15 0.08 -38.6 19.46 1.6 5.93 0.91 6.76 7.99
GMPC 342.44 1.8 0 -56.2 37.89 0.96 3 -0.05 75.81 111.42
YIACO 85.13 141 0 -45.77 -2.7 2.63 0 0.19 -8.47 -63.6
QGMD 16.81 5.27 -1.5 -40.09 -2.85 0.89 0 0.89 -6.18 0
NPMI 15.04 0.12 0 2.65 3.49 0.73 11.67 -0.03 6.11 0